REQUEST A DEMO
Total
USD $0.00
Search more companies

Gulkas Pharma Pvt Ltd (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gulkas Pharma Pvt Ltd Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Gulkas Pharma Pvt Ltd is based in India. The head office is in Gandhinagar. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on December 28, 1990. In 2025, the company reported a net sales revenue increase of 21.06%. Its total assets grew by 18.71% over the same period. Gulkas Pharma Pvt Ltd’s net profit margin increased by 0.42% in 2025.

Legal Address
Plot No 914Phase I, Gidc Chhatral
Gandhinagar; Gujarat; Postal Code: 382729

Contact Details: Purchase the Gulkas Pharma Pvt Ltd report to view the information.

Basic Information
Registered Capital:
Purchase the Gulkas Pharma Pvt Ltd report to view the information.
Financial Auditors:
Purchase the Gulkas Pharma Pvt Ltd report to view the information.
Incorporation Date:
December 28, 1990
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Gulkas Pharma Pvt Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
21.06%
Total Operating Revenue
21.46%
Operating Profit
64.23%
EBITDA
60.97%
Net Profit/Loss for the Period
268.69%
Total Assets
18.71%
Total Equity
12.89%
Operating Profit Margin
0.37%
Net Profit Margin
0.42%
Return on Equity (ROE)
7.92%
Debt / Equity
-73%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?